David Mai
Foot & Ankle Surgery · Miami Lakes, FLNPI 1972826808
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $138,875 of the $179,573 with a category attached, or 77.3%. AbbVie accounts for 80.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $77,204 and has fallen 94.1% since, to $4,574 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 504 payments — averaging $356.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$145K
- Merck$24K
- Medimetriks Pharmaceuticals, Inc.$4K
- Amgen$3K
- HNM Stainless, LLC$1K
- ANI Pharmaceuticals, Inc.$350
- plus $2K from 17 others
What the payments were for
- Consulting fees$4,4002%
- Speaking & faculty fees$138,87577%
- Travel & lodging$26,86215%
- Food & beverage$9,4365%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 334 | $145,071 |
| Merck | 53 | $23,602 |
| Medimetriks Pharmaceuticals, Inc. | 12 | $4,322 |
| Amgen | 41 | $3,334 |
| HNM Stainless, LLC | 4 | $1,123 |
| ANI Pharmaceuticals, Inc. | 1 | $350 |
| HNM Total Recon | 1 | $338 |
| Organogenesis Inc. | 6 | $310 |
| Kowa Pharmaceuticals America, Inc. | 18 | $228 |
| Melinta Therapeutics, LLC | 11 | $198 |
| Flower Orthopedics Coporation | 1 | $132 |
| Stryker | 2 | $116 |
| Embody, Inc. | 1 | $81 |
| Vertex | 3 | $63 |
| Treace Medical Concepts, Inc. | 3 | $62 |
| Nabriva Therapeutics, PLC | 3 | $60 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Johnson & Johnson | 1 | $25 |
| ERMI LLC | 1 | $24 |
| Integra Lifesciences Corporation | 2 | $23 |
| DJO, LLC | 1 | $22 |
| Smith+Nephew | 1 | $20 |
| Baudax Bio Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$141,012
- SIVEXTRO$23,175
- RAYOS$9,058
- Neo-Synalar$4,050
- Ketodan$1,050
- Genadur$350
- Tovet (emollient formulation)$350
- VEREGEN$350
- Apligraf$124
- PURAPLY WOUND MATRIX$121
- Clindacin PAC$115
How this compares
$179,573 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 31 | $1,280 |
| Celecoxib | 24 | $408 |
| Diclofenac Sodium | 44 | $335 |
| CiclopiroxCiclopirox Olamine | 19 | $262 |
| Prednisone | 29 | $131 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $131 |
| Meloxicam | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Miami Lakes
- Rafael LappostMiami Lakes$319K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.